SVR@ in the combined immediate treatment group and intensive pharmacokinetic population was @ % ( @ % CI @-@ ; @/@ ) , with one relapse @ weeks after end of treatment when compared with a historical control of @ % , based on meta-analyses of interferon-based regimens used in clinical trials of patients infected with HCV who are on haemodialysis .